NCT00541762View on ClinicalTrials.gov

Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Fat perfusion to the small intestine

"1. Triglycerides, long chain fatty acids, medium chain fatty acids perfused to the small intestine~2. Orlistat perfused to the small intestine~3. DEXLOX as CCK-1 receptor antagonist"

Trial Locations (1)

CH-4031

Clinical Research Center, University Hospital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00541762 - Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects | Biotech Hunter | Biotech Hunter